Supportive Care News

CancerConnect supportive care news, tips, and features provide breaking research stories, helpful tips, and inspiring features related to ovarian cancer. The unique daily cancer news service evaluates all aspects of supportive care research and reports on the developments that are most important to cancer patients and healthcare providers, while the tips and features offer insight into all aspects of supportive care treatment and survivorship.

Share

Supportive Care News


Recognizing the Early Signs of Anemia (February 9, 2017)

Anemia (an inadequate supply of red blood cells) can cause symptoms such as fatigue, shortness of breath, and dizziness. Other possible signs of this condition include rapid heartbeat, chest pain, difficulty... Continue Reading

Syndros™ Approved for Treating Chemotherapy-Induced Nausea and Vomiting (July 12, 2016)

The orally administered liquid formulation, Syndros (dronabinol), has been approved by the United States Food and Drug Administration (FDA) for the treatment of chemotherapy-induced nausea and vomiting.... Continue Reading

Nonsteroidal Anti-inflammatory Drugs (NSAIDs) and Risk of Serious Stomach Problems (May 5, 2016)

By David Borenstein, MD, Managing Editor theSpineCommunity.com Nonsteroidal anti-inflammatory drugs (NSAIDs) are a class of drugs used for a wide range of musculoskeletal disorders. They can decrease pain... Continue Reading

Marriage May Have a Protective Effect for Cancer Patients (December 17, 2013)

Social support may have a significant impact on cancer detection, treatment, and survival, according to the results of a study published in the Journal of Clinical Oncology. The study showed that married... Continue Reading

Yoga Improves Sleep Quality in Cancer Survivors (September 11, 2013)

Cancer survivors who participated in a special yoga program reported better sleep quality and less reliance on sleep medication, according to the results of a study published in the Journal of Clinical... Continue Reading

Ginseng Supplements May Relieve Cancer-Related Fatigue (August 14, 2013)

Cancer patients and survivors who took ginseng supplements for two months felt noticeable relief from fatigue, according to the results of a study published in the Journal of the National Cancer Institute. Fatigue... Continue Reading

Neulasta Significantly Reduces Febrile Neutropenia Among Colorectal Cancer Patients Receiving Chemotherapy Plus Avasatin (July 15, 2013)

Neulasta® (pegfilgrastim) significantly reduced the incidence of grade 3/4 febrile neutropenia among patients with locally advanced or metastatic colorectal cancer who received chemotherapy with FOLFOX... Continue Reading

Antidepressant Cymbalta May Reduce Pain from Chemotherapy-Induced Peripheral Neuropathy (May 24, 2013)

The antidepressant Cymbalta® (duloxetine) appears to reduce the numbness and tingling associated with taxane or platinum-based chemotherapy, according to the results of a study published in the Journal... Continue Reading

Exercise Reduces Cancer-Related Fatigue (November 30, 2012)

Aerobic exercise can relieve the fatigue associated with cancer and its treatment, according to an updated systematic review published in The Cochrane Library. Fatigue is one of the most common side effects... Continue Reading

Antidepressant Cymbalta Might Tame Post-Chemotherapy Pain (August 3, 2012)

The antidepressant Cymbalta® (duloxetine) appears to reduce the numbness and tingling associated with taxane or platinum-based chemotherapy, according to the results of a study presented at the 2012 annual... Continue Reading

More Supportive Care News

Latest Supportive Care News By Stage


Management and Prevention of Anemia

Recognizing the Early Signs of Anemia (February 9, 2017)

Anemia (an inadequate supply of red blood cells) can cause symptoms such as fatigue, shortness of breath, and dizziness. Other possible signs of this condition include rapid heartbeat, chest pain, difficulty staying warm, loss of sex drive, and pale skin.... Continue Reading

Anemia Common in Lung Cancer Patients (October 20, 2010)

A European study of anemia and cancer reports that anemia is common in lung cancer patients and often untreated. Results from the European Cancer Anemia Survey (ECAS) suggest that anemia is common in lung cancer patients and that current treatment patterns... Continue Reading

Age of Blood Used for Transfusions May Affect Incidence of Infection (November 4, 2008)

Age of Blood Used for Transfusions May Affect Incidence of Infection Blood used for blood transfusions stored longer than 29 days was associated with an increased risk of infection compared with blood stored for a shorter period. The details of this study... Continue Reading

Chemotherapy-induced Anemia Associated with Breast Cancer Recurrence (April 10, 2008)

A recent study conducted in Austria reveals that in premenopausal women with localized breast cancer, chemotherapy-induced anemia is associated with local recurrence following treatment. Full details of this study were published in the April issue of... Continue Reading

Further Review of Anemia Drugs by FDA (January 11, 2008)

Further Review of Anemia Drugs by FDA The United States Food and Drug Administration (FDA) has announced that it is reviewing new data regarding erythropoiesis-stimulating agents (ESAs). ESAs are drugs used to treat anemia. They include Procrit® (epoetin... Continue Reading

More Management and Prevention of Anemia

Management and Prevention of Anorexia and Weight Loss

Anamorelin May Be First Drug to Treat Cancer Cachexia (October 14, 2014)

A new drug, anamorelin, may be the first ever to effectively improve cancer cachexia. These findings were presented at the 2014 European Society for Medical Oncology (ESMO) Congress in Madrid, Spain, September 26–30.[1] Cancer cachexia is a “wasting”... Continue Reading

Fish Oil May Help Patients Maintain Weight During Chemotherapy (March 8, 2011)

Fish oil, taken as a dietary supplement, may help prevent muscle and weight loss among cancer patients who are undergoing chemotherapy. These findings were reported in the journal Cancer. Loss of muscle and weight is a potential side effect of chemotherapy... Continue Reading

Celebrex® May Improve Cachexia in Some Patients with Cancer (August 13, 2007)

Celebrex® May Improve Cachexia in Some Patients with Cancer According to an early online article recently published in the journal Head and Neck, treatment of patients with cancer cachexia with Celebrex® (celecoxib) resulted in weight gain, increased... Continue Reading

Vitor™ Slows Cachexia in Cancer Patients (January 17, 2006)

Vitor™ Slows Cachexia in Cancer Patients According to results from a recent clinical trial, the oral agent Vitor™ slows the progression of cachexia in patients with colon cancer and non-small cell lung cancer. Anorexia is the lack or loss of appetite,... Continue Reading

Fish Oil Appears Ineffective for Anorexia/Cachexia in Advanced Cancer Patients (April 22, 2003)

Fish Oil Appears Ineffective for Anorexia/Cachexia in Advanced Cancer Patients According to an article recently published in the Journal of Clinical Oncology, fish oil does not appear effective at reducing anorexia or cachexia experienced by... Continue Reading

More Management and Prevention of Anorexia and Weight Loss

Management and Prevention of Bone Complications

Xgeva Reduces Bone Complications From Prostate Cancer (February 25, 2011)

Among men with bone metastases from prostate cancer, Xgeva™ (denosumab) was more effective than Zometa® (zoledronic acid) at delaying or preventing bone complications such as fracture. Results from this Phase III clinical trial were published in The... Continue Reading

Xgeva Delays Bone Complications in Women with Metastatic Breast Cancer (December 21, 2010)

In a study of women with bone metastases from breast cancer, Xgeva™ (denosumab) delayed bone complications for five months longer than Zometa® (zoledronic acid). These updated results from a Phase III clinical trial were presented at the 2010 San Antonio... Continue Reading

Xgeva Approved for Patients with Bone Metastases (November 30, 2010)

Xgeva™ (denosumab) has been approved by the US Food and Drug Administration (FDA) for the prevention of bone complications such as fracture in patients with bone metastases from solid (not blood-related) cancers. It is not approved for patients with... Continue Reading

Denosumab Delays Bone Complications in Women with Metastatic Breast Cancer (November 23, 2010)

Among women with bone metastases from breast cancer, denosumab may be more effective than Zometa® (zoledronic acid) at delaying or preventing bone complications such as fracture. The results of this Phase III clinical trial were published in the Journal... Continue Reading

Denosumab More Effective Than Zometa at Delaying Bone Complications (October 15, 2010)

Among patients with multiple myeloma or bone metastases from breast cancer, prostate cancer, or other solid tumors, denosumab was more effective than Zometa® (zoledronic acid) at delaying or preventing bone complications such as fracture. Results from... Continue Reading

More Management and Prevention of Bone Complications

Management and Prevention of Fatigue

Yoga Improves Sleep Quality in Cancer Survivors (September 11, 2013)

Cancer survivors who participated in a special yoga program reported better sleep quality and less reliance on sleep medication, according to the results of a study published in the Journal of Clinical Oncology. Sleep problems and fatigue are among the... Continue Reading

Ginseng Supplements May Relieve Cancer-Related Fatigue (August 14, 2013)

Cancer patients and survivors who took ginseng supplements for two months felt noticeable relief from fatigue, according to the results of a study published in the Journal of the National Cancer Institute. Fatigue is one of the most common side effects... Continue Reading

Exercise Reduces Cancer-Related Fatigue (November 30, 2012)

Aerobic exercise can relieve the fatigue associated with cancer and its treatment, according to an updated systematic review published in The Cochrane Library. Fatigue is one of the most common side effects of cancer and its treatment. There are many... Continue Reading

Yoga Improves Sleep and Quality of Life (May 26, 2010)

A four-week yoga program that included breathing, meditation, postures, and other techniques improved sleep and quality of life among cancer survivors. The results of this study will be presented at the 2010 annual meeting of the American Society of Clinical... Continue Reading

Exercise Reduces Chemotherapy-related Fatigue (October 21, 2009)

Exercise reduces fatigue and improves strength, physical functioning, and emotional well-being in men and women undergoing chemotherapy, according to the results of a study published in the British Medical Journal.[1] While exercise has long been associated... Continue Reading

More Management and Prevention of Fatigue

Management and Prevention of Mucositis

Kepivance Reduces Toxicity of High-dose Therapy for Multiple Myeloma (March 24, 2010)

Among patients undergoing high-dose therapy and autologous stem cell transplantation for multiple myeloma, a three-day short course of Kepivance® (palifermin) reduces the toxicity of treatment. These results were published in the Annals of Oncology. Multiple... Continue Reading

Oral Spray Reduces Mouth Sores (July 21, 2009)

Among patients treated with radiation therapy for head and neck cancer, mouth sores (oral mucositis) were reduced by use of an oral spray containing epidermal growth factor (EGF). These results were published in Cancer. Mouth sores are one of the most... Continue Reading

Update on the Management of Mucositis (November 5, 2007)

Update on the Management of Mucositis: A Report from the 2007 MASCC/ISOO International Symposium Introduction The fact that mucositis remains an important toxicity of cancer therapy was reflected in the thirty abstracts dealing with this topic that were... Continue Reading

Supportive Care Issues in Head and Neck Cancer: A Report from ASCO 2007 (October 12, 2007)

Supportive Care Issues in Head and Neck Cancer: A Report from ASCO 2007 Introduction With the use of combined modality therapy, clinical outcomes for locally advanced head and neck cancer (HNC) have improved dramatically over the past two decades. Unfortunately,... Continue Reading

Kepivance® May Decrease Oral Mucositis Following High-dose Chemotherapy for Hematologic Cancers (January 10, 2007)

Kepivance® May Decrease Oral Mucositis Following High-dose Chemotherapy for Hematologic Cancers Several studies presented at the 2006 meeting of the American society of Hematology in December suggest that Kepivance® (palifermin) decreases the frequency,... Continue Reading

More Management and Prevention of Mucositis

Management and Prevention of Nausea and Vomiting

Syndros™ Approved for Treating Chemotherapy-Induced Nausea and Vomiting (July 12, 2016)

The orally administered liquid formulation, Syndros (dronabinol), has been approved by the United States Food and Drug Administration (FDA) for the treatment of chemotherapy-induced nausea and vomiting. Syndros is an oral formulation comparable to the... Continue Reading

Arrhythmia Risk Leads to Label Change for Zofran (July 9, 2012)

Interim data from a recent clinical trial has indicated that a 32 mg single dose of Zofran® (ondansetron) may affect the electrical activity of the heart and could predispose patients to develop an abnormal heart rhythm. The U.S. Food and Drug Administration... Continue Reading

Study Suggests Long-acting Patch that Prevents Nausea and Vomiting Can Be Given in Combination with Intravenous Medication (February 9, 2010)

Use of a combination of Sancuso® (granisetron transdermal system; a patch that delivers granisetron through the skin for up to five days) and intravenous granisetron appears to be safe and feasible. This approach may provide immediate and extended management... Continue Reading

Sancuso® Approved for Chemotherapy-induced Nausea and Vomiting (September 15, 2008)

Sancuso® Approved for Chemotherapy-induced Nausea and Vomiting The United States Food and Drug Administration (FDA) has approved Sancuso® (Granisetron Transdermal System) for the treatment of chemotherapy-induced nausea and vomiting (CINV). Sancuso... Continue Reading

More than Half of Oncology Nurses Stop or Delay Chemotherapy Due to Nausea and Vomiting (June 24, 2008)

More than Half of Oncology Nurses Stop or Delay Chemotherapy Due to Nausea and Vomiting More than half of oncology nurses will completely stop or delay their patients’ chemotherapy regimens due to nausea and vomiting induced by therapy. Such findings... Continue Reading

More Management and Prevention of Nausea and Vomiting

Management and Prevention of Neutropenia

Neulasta Significantly Reduces Febrile Neutropenia Among Colorectal Cancer Patients Receiving Chemotherapy Plus Avasatin (July 15, 2013)

Neulasta® (pegfilgrastim) significantly reduced the incidence of grade 3/4 febrile neutropenia among patients with locally advanced or metastatic colorectal cancer who received chemotherapy with FOLFOX or FOLFIRI followed by Avastin® (bevacizumab),... Continue Reading

Naproxen May Relieve Bone Pain Associated with Neulasta (August 2, 2012)

Twice-daily naproxen is effective in reducing the incidence and severity of bone pain associated with the use of Neulasta® (pegfilgrastim), according to the results of a study published in the Journal of Clinical Oncology. Neulasta is a blood cell growth... Continue Reading

Celebrities Stand Up to Cancer (September 14, 2009)

Celebrities and Amgen are joining forces to Stand Up to Cancer™—in the form of a public service campaign designed to educate cancer patients and caregivers about managing the increased risk of infection during cancer treatment. Chemotherapy is an... Continue Reading

Amgen Helps Reduce Out-of-pocket Costs for Neulasta® (July 2, 2009)

Amgen’s Neulasta FIRST STEP™ Program provides assistance to eligible, low-income, commercially-insured chemotherapy patients who need help with their co-insurance or co-payment requirement for Neulasta® (pegfilgrastim). Neulasta is a blood cell growth... Continue Reading

Dose Intensity Associated with Survival in Non-Hodgkin’s Lymphoma (September 9, 2008)

Dose Intensity Associated with Survival in Non-Hodgkin’s Lymphoma Relative dose intensity (RDI) remains a key factor in the outcomes of patients with non-Hodgkins lymphoma (NHL). These results have been validated in several multicenter clinical... Continue Reading

More Management and Prevention of Neutropenia

Management and Prevention of Thrombocytopenia

Nplate Produces Rapid Response in Adults with ITP (December 20, 2011)

Among adults with low platelet counts or bleeding symptoms from primary immune thrombocytopenia (ITP), treatment with Nplate® (romiplostim) produces a rapid increase in platelet counts. These results were presented at the 53rd Annual Meeting of the American... Continue Reading

Nplate Active for More than Five Years in Adults with Chronic ITP (December 13, 2010)

Nplate® (romiplostim) appears to maintain platelet counts among adult patients with chronic immune (idiopathic) thrombocytopenia purpura (ITP) for more than five years. These results were presented at the 52nd Annual Meeting and Exposition of the American... Continue Reading

Nplate Reduces Treatment Failure and Splenectomy in Patients with ITP (November 17, 2010)

Compared with standard therapies, Nplate® (romiplostim) appears to reduce the risk of treatment failure and need for splenectomy among adult patients with chronic immune thrombocytopenia (ITP). These results were published in the New England Journal... Continue Reading

Nplate Evaluated in Children with Chronic ITP (December 8, 2009)

Among children with chronic immune thrombocytopenic purpura (ITP; an autoimmune disorder characterized by low platelet counts), treatment with Nplate® (romiplostim) stimulates platelet production and appears to be well tolerated. These results were presented... Continue Reading

Nplate® Approved for Thrombocytopenia in Patients with ITP (August 25, 2008)

Nplate® Approved for Thrombocytopenia in Patients with ITP The U.S. Food and Drug Administration (FDA) has approved the use of Nplate® (romiplostim) for the treatment of thrombocytopenia in adult patients with chronic immune (idiopathic) thrombocytopenic... Continue Reading

More Management and Prevention of Thrombocytopenia

Pain Management

Nonsteroidal Anti-inflammatory Drugs (NSAIDs) and Risk of Serious Stomach Problems (May 5, 2016)

By David Borenstein, MD, Managing Editor theSpineCommunity.com Nonsteroidal anti-inflammatory drugs (NSAIDs) are a class of drugs used for a wide range of musculoskeletal disorders. They can decrease pain and inflammation in patients with rheumatoid arthritis,... Continue Reading

Over Regulation of Opioids May Leave Cancer Patients in Pain (December 3, 2013)

A worldwide trend toward over-regulation of opioid-based painkillers such as morphine and fentanyl is leaving billions of cancer patients to suffer intolerable pain, according to the results of a study published in the Annals of Oncology. Many cancer... Continue Reading

Antidepressant Cymbalta May Reduce Pain from Chemotherapy-Induced Peripheral Neuropathy (May 24, 2013)

The antidepressant Cymbalta® (duloxetine) appears to reduce the numbness and tingling associated with taxane or platinum-based chemotherapy, according to the results of a study published in the Journal of the American Medical Association. Peripheral... Continue Reading

Antidepressant Cymbalta Might Tame Post-Chemotherapy Pain (August 3, 2012)

The antidepressant Cymbalta® (duloxetine) appears to reduce the numbness and tingling associated with taxane or platinum-based chemotherapy, according to the results of a study presented at the 2012 annual meeting of the American Society of Clinical... Continue Reading

Acupuncture Relieves Pain, Improves Functioning After Neck Surgery (April 28, 2010)

Acupuncture may reduce pain and improve functioning among patients with cancer who have undergone surgery to the neck, according to a study published in the Journal of Clinical Oncology.[1] As well, acupuncture may relieve xerostomia (dry mouth) among... Continue Reading

More Pain Management

CancerConnect Cancer Commuity & Discussions


Cancer Types

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS